Beatriz Perdiguero
Beatriz Perdiguero
Investigador en Centro Nacional de Biotecnología
Verified email at cnb.csic.es
Title
Cited by
Cited by
Year
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome
J Delaloye, T Roger, QG Steiner-Tardivel, D Le Roy, MK Reymond, ...
PLoS Pathog 5 (6), e1000480, 2009
3412009
The interferon system and vaccinia virus evasion mechanisms
B Perdiguero, M Esteban
Journal of Interferon & Cytokine Research 29 (9), 581-598, 2009
1912009
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
BJ Flynn, K Kastenmüller, U Wille-Reece, GD Tomaras, M Alam, ...
Proceedings of the National Academy of Sciences 108 (17), 7131-7136, 2011
1522011
The evolution of poxvirus vaccines
L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez, J García-Arriaza, ...
Viruses 7 (4), 1726-1803, 2015
1282015
MVA and NYVAC as vaccines against emergent infectious diseases and cancer
C E Gomez, J L Najera, M Krupa, B Perdiguero, M Esteban
Current gene therapy 11 (3), 189-217, 2011
1222011
Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein
MM Geada, I Galindo, MM Lorenzo, B Perdiguero, R Blasco
Journal of General Virology 82 (11), 2747-2760, 2001
1182001
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens
CE Gómez, JL Nájera, B Perdiguero, J García-Arriaza, COS Sorzano, ...
Journal of virology 85 (21), 11468-11478, 2011
782011
Poxvirus vectors as HIV/AIDS vaccines in humans
C Elena Gomez, B Perdiguero, J García-Arriaza, M Esteban
Human vaccines & immunotherapeutics 8 (9), 1192-1207, 2012
762012
Clinical applications of attenuated MVA poxvirus strain
CE Gómez, B Perdiguero, J García-Arriaza, M Esteban
Expert review of vaccines 12 (12), 1395-1416, 2013
732013
Improved NYVAC-based vaccine vectors
KV Kibler, CE Gomez, B Perdiguero, S Wong, T Huynh, S Holechek, ...
PloS one 6 (11), e25674, 2011
732011
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1 …
F García, JCLB de Quirós, CE Gómez, B Perdiguero, JL Nájera, ...
Vaccine 29 (46), 8309-8316, 2011
712011
Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein
J Falivene, MPDM Zajac, MF Pascutti, AM Rodríguez, C Maeto, ...
PloS one 7 (2), e32220, 2012
612012
Cryo X-ray nano-tomography of vaccinia virus infected cells
FJ Chichón, MJ Rodríguez, E Pereiro, M Chiappi, B Perdiguero, ...
Journal of structural biology 177 (2), 202-211, 2012
522012
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1
B Mothe, N Climent, M Plana, M Rosàs, JL Jiménez, ...
Journal of Antimicrobial Chemotherapy 70 (6), 1833-1842, 2015
512015
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors
ED Quakkelaar, A Redeker, EK Haddad, A Harari, SM McCaughey, ...
PloS one 6 (2), e16819, 2011
512011
Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins
B Perdiguero, R Blasco
Journal of virology 80 (17), 8763-8777, 2006
402006
Head-to-head comparison of poxvirus NYVAC and ALVAC vectors expressing identical HIV-1 clade C immunogens in prime-boost combination with Env protein in nonhuman primates
J García-Arriaza, B Perdiguero, J Heeney, M Seaman, DC Montefiori, ...
Journal of virology 89 (16), 8525-8539, 2015
392015
Comparison of immunogenicity in rhesus macaques of transmitted-founder, HIV-1 group M consensus, and trivalent mosaic envelope vaccines formulated as a DNA prime, NYVAC, and …
SL Hulot, B Korber, EE Giorgi, N Vandergrift, KO Saunders, ...
Journal of virology 89 (12), 6462-6480, 2015
372015
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens
B Perdiguero, CE Gómez, JL Nájera, COS Sorzano, J Delaloye, ...
PloS one 7 (10), e48524, 2012
372012
High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus …
CE Gómez, B Perdiguero, MV Cepeda, L Mingorance, J García-Arriaza, ...
Journal of virology 87 (13), 7282-7300, 2013
332013
The system can't perform the operation now. Try again later.
Articles 1–20